Skip to main content
. 2019 May 8;42(2):107–115. doi: 10.1016/j.bj.2018.12.005

Table 2.

Correlations between each biomarker and the risk of ACS development.

Biomarker OR (95% CI) p-value
MPV 5.083 (1.902–13.586) <0.001***
IPF 0.962 (0.644–1.436) 0.850
Initial TnI 1.376 (1.041–1.821) 0.025*
CK-MB 0.992 (0.979–1.005) 0.241

Aberrations: OR: odds ratio.

*, p < 0.05; ***, p < 0.001.